KBC Group’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

KBC Group’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,954	Closed	-$65K	–	1876
2024 Q3	$65K	Buy	+1,954	New	+$67.3K	﹤0.01%	1581

KBC Group's LBPH Position: Q4 2024 in Review

KBC Group sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 1,954 shares — an estimated $65K sold.

KBC Group first reported a position in LBPH in Q3 2024 and held it in 1 quarter. The position peaked at $65K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

KBC Group reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
KBC Group sold 1,954 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $65K.
KBC Group first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
KBC Group's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $65K in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on KBC Group's 13F filing for Q4 2024, filed 22 Jan 2025.